Biosimilar Safe Harbors Need Record Of Non-Commercial Use, Epogen Ruling Suggests

 
• By Brenda Sandburg
  
Wollongong lighthouse providing safe harbor
Federal Circuit finds Hospira's Epogen biosimilar batches were outside safe harbor from infringement suit
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics